| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/24/2008 | WO2008011194A2 Transmucosal delivery devices with enhanced uptake |
| 01/24/2008 | WO2008011177A2 Medicinal delivery system and related methods |
| 01/24/2008 | WO2008011169A2 Controlled release formulations and associated methods |
| 01/24/2008 | WO2008011154A2 Formulations for benzimidazolyl pyridyl ethers |
| 01/24/2008 | WO2008011087A2 Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease |
| 01/24/2008 | WO2008011051A1 Nanoparticle fabrication methods, systems, and materials |
| 01/24/2008 | WO2008010953A2 Pyridinone diketo acids: inhibitors of hiv replication in combination therapy |
| 01/24/2008 | WO2008010788A2 Compositions and methods for making and using nanoemulsions |
| 01/24/2008 | WO2008010741A1 Method for micronising organic medicinal substances |
| 01/24/2008 | WO2008010697A1 Curcumin-based drug for the treatment of parasitic infection caused by giardia lamblia |
| 01/24/2008 | WO2008010690A1 Gastric retention-type pellet and the preparation method thereof |
| 01/24/2008 | WO2008010524A1 Process for producing spherical elementary granule containing readily water-soluble drug |
| 01/24/2008 | WO2008010472A1 Total enteral nutrition composition |
| 01/24/2008 | WO2008010362A1 Powder of vitamin e/proline complex and method of producing the same |
| 01/24/2008 | WO2008010341A1 Physiologically active polypeptide, polymer micelle having protein enclosed therein, and process for production of the polymer micelle |
| 01/24/2008 | WO2008010241A1 A liposomal complex of sodium carboxymethyl beta-glucan |
| 01/24/2008 | WO2008009804A2 Multilayer tablet having a disintegration layer |
| 01/24/2008 | WO2008009756A1 Injectable liquid paracetamol formulation |
| 01/24/2008 | WO2008009689A1 Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same |
| 01/24/2008 | WO2008009664A2 Treatment of pain |
| 01/24/2008 | WO2008009617A1 Products containing smart foam and method of making |
| 01/24/2008 | WO2008009589A2 Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient |
| 01/24/2008 | WO2008009476A2 Concentrated methotrexate solutions |
| 01/24/2008 | WO2008009361A2 Multicompartment granulate formulations for active substances |
| 01/24/2008 | WO2008009212A1 A standardised extract and its use in the manufacture of a medicament |
| 01/24/2008 | WO2008009172A1 Controlled release composition and preparation thereof |
| 01/24/2008 | WO2007143651A3 Chewable co-enzyme q-10 capsule |
| 01/24/2008 | WO2007143411A3 Use of a botulinum toxin for treating a urethral stricture |
| 01/24/2008 | WO2007143410A3 Use of a botulinum toxin for treating a urethral stricture |
| 01/24/2008 | WO2007138606A3 Multiple unit pharmaceutical formulation |
| 01/24/2008 | WO2007137040A3 7-(acryloyl) indole compositions and methods for making and using same |
| 01/24/2008 | WO2007135172A3 Cladribine regimen for treating multiple sclerosis |
| 01/24/2008 | WO2007133802A3 Pharmaceutical formulations of pimavanserin |
| 01/24/2008 | WO2007133711A3 Pharmaceutical compositions for vein irritating drugs |
| 01/24/2008 | WO2007130478A3 Heated roller compaction process for making pharmaceutical compositions |
| 01/24/2008 | WO2007101068A3 Methods of treating cystic fibrosis |
| 01/24/2008 | WO2007095147A3 Adhesive preparation comprising sufentanil and methods of using the same |
| 01/24/2008 | WO2007093305A3 Low-friability, patient-friendly orally disintegrating formulations |
| 01/24/2008 | WO2007088343A3 Granular material comprising water- insoluble inorganic phosphate binders |
| 01/24/2008 | WO2007077581A3 Pharmaceutical compositions |
| 01/24/2008 | WO2007070307A3 Intravenous essential fatty acid emulsion |
| 01/24/2008 | WO2007062023A3 Items containing a human pheromone component |
| 01/24/2008 | WO2007049265A3 Anti mineralocorticoid therapy of infection |
| 01/24/2008 | WO2006138026A8 Stable pharmaceutical compositions including motilin-like peptides |
| 01/24/2008 | WO2006127069A3 A delivery system for active components as part of an edible composition including a ratio of encapsulating material and active component |
| 01/24/2008 | WO2006031833B1 Ultra-violet inhibition system |
| 01/24/2008 | WO2005120578A3 Biodegradable drug-polymer delivery system |
| 01/24/2008 | WO2004103299A3 Compositions and methods for the treatment of cns injuries |
| 01/24/2008 | US20080021519 Communication Unit for a Person's Skin |
| 01/24/2008 | US20080021421 Acupoint patch |
| 01/24/2008 | US20080021411 Lipid Emulsions in the Treatment of Systemic Poisoning |
| 01/24/2008 | US20080021379 Drug delivery in association with medical or surgical procedures |
| 01/24/2008 | US20080021106 Cellular uptake of bioactive agents |
| 01/24/2008 | US20080021103 Mucoadhesive composition |
| 01/24/2008 | US20080021102 Method for the Management of Incontinence |
| 01/24/2008 | US20080020993 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules |
| 01/24/2008 | US20080020065 Rapid-melt compositions, methods of making same and method of using same |
| 01/24/2008 | US20080020063 Anti-angiogenic compositions and methods of use |
| 01/24/2008 | US20080020058 One or more short interfering RNA, 3-dimethylamino-2-(cholest-5-en-3-beta-oxybutan-4-oxy)-1-(cis,cis-9,12-octadecadienoxy) propane, distearoyl phosphatidylcholine, cholesterol, and 1-[8'-(1,2-Dimyristoyl-3-propanoxy)-carboxamido-3',6'-dioxaoctanyl]carbamoyl-omega-methyl-polyethylene glycol; transfection |
| 01/24/2008 | US20080020057 Personal care composition containing microemulsified wax particles |
| 01/24/2008 | US20080020056 Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease |
| 01/24/2008 | US20080020055 Phenylephrine Pharmaceutical Formulations and Compositions for Colonic Absorption |
| 01/24/2008 | US20080020054 Cosmetic and Dermatological Preparations Containing Transparent Surface-Coated Titanium Dioxide Particles |
| 01/24/2008 | US20080020053 Solid Dosage Form Comprising Proton Pump Inhibitor and Suspension Made Thereof |
| 01/24/2008 | US20080020052 Vascular Embolus Of Paclitaxel-Sodium Alginate Microsphere And Its Preparation |
| 01/24/2008 | US20080020051 adsorbing active drug in porous templates, coating a primer layer and forming a capsule shell, alternately coating the charged poly-electrolyte layers and nanoparticle layers; sustained release; dosage forms; cosmetics; as diagnosis, sensors; water treatment |
| 01/24/2008 | US20080020050 Medicinal delivery system, and related methods |
| 01/24/2008 | US20080020049 Super-sparger microcarrier beads and precision extrusion deposited poly-epsilon-caprolactone structures for biological applications |
| 01/24/2008 | US20080020048 Treatment of Respiratory Disease |
| 01/24/2008 | US20080020047 Method for distributing a pharmaceutically active compound in an excipient |
| 01/24/2008 | US20080020046 Pharmaceutical Formulations Comprising Metformin And A Fibrate, And Processes For Obtaining Them |
| 01/24/2008 | US20080020045 Combination Degradable and Non-Degradable Matrices for Active Agent Delivery |
| 01/24/2008 | US20080020044 Aqueous gel formulation and method for inducing topical anesthesia |
| 01/24/2008 | US20080020043 Dendrimer-Drug Conjugates |
| 01/24/2008 | US20080020042 Dosage form of sodium ibuprofen |
| 01/24/2008 | US20080020041 Enteric Coated Compositions that Release Active Ingredient(s) in Gastric Fluid and Intestinal Fluid |
| 01/24/2008 | US20080020040 Unit dose form for administration of ibuprofen |
| 01/24/2008 | US20080020039 Controlled Release Formulations and Associated Methods |
| 01/24/2008 | US20080020038 Amorphous Aripiprazole and Process for the Preparation thereof |
| 01/24/2008 | US20080020037 Acoustic Pharma-Informatics System |
| 01/24/2008 | US20080020036 Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers |
| 01/24/2008 | US20080020034 Butylphtualide Soft Gel Capsule and Its Preperation Procedure |
| 01/24/2008 | US20080020032 Hydrophobic abuse deterrent delivery system for hydromorphone |
| 01/24/2008 | US20080020031 Methods and compositions for altering mucus secretion |
| 01/24/2008 | US20080020030 Use Of 7-T-Butoxyiminomethylcamptothecin For The Preparation Of A Medicament For The Treatment Of Uterine Neoplasms |
| 01/24/2008 | US20080020029 Drug Delivery System Using an Immune Response System |
| 01/24/2008 | US20080020028 Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agent |
| 01/24/2008 | US20080020027 Film-Delivering Rinse |
| 01/24/2008 | US20080020026 Hemostatic compositions and methods for controlling bleeding |
| 01/24/2008 | US20080020024 Fast dissolving orally consumable films |
| 01/24/2008 | US20080020023 Nonaqueous coating composition for elastomeric articles and articles containing the same |
| 01/24/2008 | US20080020022 Chewable co-enzyme q-10 capsule |
| 01/24/2008 | US20080020019 Method of decreasing fat deposits and body weight in mammals and birds |
| 01/24/2008 | US20080020018 Combination Products |
| 01/24/2008 | US20080020017 Intraocular Irrigating Solution Having Improved Flow Characteristics |
| 01/24/2008 | US20080020015 Bioactive wound dressings and implantable devices and methods of use |
| 01/24/2008 | US20080020014 Implantable devices containing nuclear receptor ligands for the treatment of vascular and related disorders |
| 01/24/2008 | US20080020012 Collagen scaffolds, medical implants with same and methods of use |
| 01/24/2008 | US20080020011 Therapeutic implant |
| 01/24/2008 | US20080020010 Pyridinone diketo acids: inhibitors of HIV replication |